| Literature DB >> 9230158 |
Abstract
A great body of clinical evidence has been accumulated--before and without the AVID trial--showing that implantable defibrillators prolong life better than currently available antiarrhythmic drugs. With this evidence already available, we question the validity of a trial that attempted, in effect, to place a price tag on life and quality of life.Mesh:
Substances:
Year: 1997 PMID: 9230158 DOI: 10.1016/s0002-9149(97)00341-x
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778